GSK
Price
$40.80
Change
+$0.34 (+0.84%)
Updated
Jun 4 closing price
Capitalization
88.13B
55 days until earnings call
OGN
Price
$9.53
Change
+$0.09 (+0.95%)
Updated
Jun 4 closing price
Capitalization
4.73B
68 days until earnings call
Interact to see
Advertisement

GSK vs OGN

Header iconGSK vs OGN Comparison
Open Charts GSK vs OGNBanner chart's image
GSK
Price$40.80
Change+$0.34 (+0.84%)
Volume$2.94M
Capitalization88.13B
Organon & Co
Price$9.53
Change+$0.09 (+0.95%)
Volume$3.02M
Capitalization4.73B
GSK vs OGN Comparison Chart
Loading...
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GSK vs. OGN commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a Buy and OGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (GSK: $40.80 vs. OGN: $9.53)
Brand notoriety: GSK and OGN are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GSK: 52% vs. OGN: 47%
Market capitalization -- GSK: $88.13B vs. OGN: $4.73B
GSK [@Pharmaceuticals: Major] is valued at $88.13B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • GSK’s FA Score: 2 green, 3 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, GSK is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 6 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • GSK’s TA Score: 6 bullish, 3 bearish.
  • OGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GSK is a better buy in the short-term than OGN.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а +4.13% price change this week, while OGN (@Pharmaceuticals: Major) price change was +4.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.27%. For the same industry, the average monthly price growth was +2.61%, and the average quarterly price growth was +3.54%.

Reported Earning Dates

GSK is expected to report earnings on Jul 30, 2025.

OGN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+3.27% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GSK($88.1B) has a higher market cap than OGN($4.73B). GSK has higher P/E ratio than OGN: GSK (14.01) vs OGN (4.64). GSK YTD gains are higher at: 23.370 vs. OGN (-34.800). GSK has higher annual earnings (EBITDA): 9.08B vs. OGN (1.44B). GSK has more cash in the bank: 4.99B vs. OGN (693M). OGN has less debt than GSK: OGN (8.76B) vs GSK (18B). GSK has higher revenues than OGN: GSK (30.3B) vs OGN (6.26B).
GSKOGNGSK / OGN
Capitalization88.1B4.73B1,863%
EBITDA9.08B1.44B633%
Gain YTD23.370-34.800-67%
P/E Ratio14.014.64302%
Revenue30.3B6.26B484%
Total Cash4.99B693M720%
Total Debt18B8.76B205%
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GSKOGN
RSI
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 1 day ago
67%
Declines
ODDS (%)
Bearish Trend 22 days ago
53%
Bearish Trend 15 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EPOL30.220.30
+1.00%
iShares MSCI Poland ETF
RSEE29.160.14
+0.49%
Rareview Systematic Equity ETF
SHYL44.720.08
+0.17%
Xtrackers Short Duration High Yld Bd ETF
DES31.16-0.18
-0.57%
WisdomTree US SmallCap Dividend ETF
YXI11.14-0.17
-1.54%
ProShares Short FTSE China 50

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
+0.84%
NVS - GSK
61%
Loosely correlated
+0.86%
AZN - GSK
54%
Loosely correlated
+1.64%
PFE - GSK
53%
Loosely correlated
+0.17%
AMGN - GSK
50%
Loosely correlated
-0.88%
SNY - GSK
47%
Loosely correlated
+0.63%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with AMGN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+0.95%
AMGN - OGN
41%
Loosely correlated
-0.88%
BIIB - OGN
39%
Loosely correlated
+0.02%
LLY - OGN
39%
Loosely correlated
+2.01%
GSK - OGN
37%
Loosely correlated
+0.84%
SNY - OGN
35%
Loosely correlated
+0.63%
More